14208-07-2

Basic information

• Product Name: 1-[3-(piperidin-1-yl)propyl]-1,2-dihydropyridine
• CAS NO: 14208-07-2
• Molecular Formula: 2Br*C₁₃H₁₆N₂
• Molecular Weight: 206.3272
• Mol File: 14208-07-2.mol
• Article Data: 13

Chemical Properties

• Boiling Point: 332.6°C at 760 mmHg
• Flash Point: 144.7°C
• Density: 0.974g/cm³
• Vapor Pressure: 0.000145mmHg at 25°C
• Refractive Index: 1.52
• CAS DataBase Reference: 1-[3-(piperidin-1-yl)propyl]-1,2-dihydropyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-[3-(piperidin-1-yl)propyl]-1,2-dihydropyridine(14208-07-2)
• EPA Substance Registry System: 1-[3-(piperidin-1-yl)propyl]-1,2-dihydropyridine(14208-07-2)

Safety Data

• Hazardous Substances Data: 14208-07-2(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 13 carbon (C) atoms, 22 hydrogen (H) atoms, and 2 nitrogen (N) atoms.

Explanation

Dihydropyridines are a class of chemical compounds that have a six-membered ring with two nitrogen atoms and two double bonds, with two additional hydrogen atoms. This compound belongs to this class.

Explanation

Calcium channel blockers are a type of medication that inhibit the movement of calcium ions into cells, particularly smooth muscle and cardiac muscle cells. This compound is a part of this group of compounds.

Explanation

The compound primarily works by affecting the influx of calcium ions into smooth muscle cells and cardiac muscle cells, which leads to vasodilation and decreased cardiac contractility.

Explanation

The compound contains a piperidine group, which is a heterocyclic amine consisting of a six-membered ring with one nitrogen atom. This group can have various pharmacological effects.

Explanation

The specific properties and potential uses of this compound would need to be further investigated through research and testing to determine its effectiveness and safety.

Explanation

The exact pharmacological effects of this compound are not known and would require further research to understand its potential therapeutic applications.

Explanation

Further research and testing are necessary to explore the compound's properties, potential uses, and any possible side effects or risks associated with its use.

Chemical Class

Dihydropyridine derivative

Functionality

Calcium channel blocker

Mechanism of Action

Affecting calcium ion influx

Structural Feature

Piperidine group

Potential Uses

Further investigation required

Pharmacological Effects

Unknown at this stage

Research Status

Investigation and testing needed

Upstream product

• 110-86-1 pyridine 
• 109-64-8 1,3-dibromo-propane 

Downstream Products

• 10035-10-6 hydrogen bromide 
• 18820-82-1 Pyridine hydrobromide 

Relevant articles and documents

A study about excellent xanthine oxidase inhibitory effects of new pyridine salts

A series of pyridine salts were synthesized containing vitamin B3 (niacin), isonicotinonitrile, and non-substituted pyridine fragment from reactions of 1,3-dibromopropane, 1,4-dibromobutane, and 4,4′-bis(chloromethyl)-1,1′-biphenyl reactants with pyridine

Synthesis and properties of new (μ-oxo)bis[trichloroferrate(III)] dianion salts incorporated with dicationic moiety

New (μ-oxo)bis[trichloroferrate(III)] dianions-based ionic compounds that contain various counterdications were synthesized and characterized with regards to their crystal structures, thermal properties, and magnetic susceptibility. These salts are soluble in polar solvents such as methanol and water. The melting point of these compounds is affected by the dication following the order of triphenylphosphinium > pyridinium > imidazolium dications, and symmetrical dicationic salts > unsymmetrical ones. In these compounds, the trichloroferrate dianion exists in either a linear or a bent form, which is affected by the dications. Interestingly, the dicationic diferrate compounds show magnetic coupling constants fairly smaller than those reported in literature for diferrate salts in which monocations are the counterion. Furthermore, unlike the diferrate salts associated with separate monocations, the linear diferrate dicationic compounds show magnetic coupling constant lower than that of bent diferrate dicationic salts.

Halobismuthates with bis(pyridinium)alkane cations: Correlations in crystal structures and optical properties

A series of four chloro- and bromobismuthates with bis(pyridinium)alkane cations (Py(CH2)nPy)2+(Cn) and (4-PyH)(CH2)n(4-PyH)2+(H2Cn) were synthesized and characterized. Analysis of their crystal structures, as well as previously reported data, results in establishment of correlations between the type of halobismuthate anion and the nature of cation. Luminescent properties of obtained compounds are reported and discussed.

Mono- and Binuclear Chloride and Bromide Complexes of Bi(III) with Double-Charged Cations Based on Pyridine: Syntheses and Crystal Structures

Abstract: The reactions of solutions obtained by the reactions of Bi2O3 with 2 M HCl and HBr with the salts containing bis(pyridyl)alkane cations afford mono- and binuclear halide complexes (Py-(CH2)3-Py)3[Bi2Br9]2 (I), (H3O)(Py-(CH2)4-Py)[BiCl6] ? 3H2O (II), and (H2Bpp)2[Bi2Br10] ? 2H2O (Bpp is 1,3-bis(4-pyridyl)propane) (III). The structures of the synthesized compounds are determined by X-ray diffraction analysis (СIF files CCDC no. 1583338–1583340, respectively).